---
$id: https://graph.org.ai/products/commodity/51142501
$type: Product
source: UNSPSC
code: "51142501"
title: "Bromocriptine"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bromocriptine

**UNSPSC Code**: 51142501
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a neuroprotective agent with the molecular formula C32H40BrN5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3A64E3G5ZO, chemically known as ergotaman-3,6,18-trione, 2-bromo-12-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-, (5.alpha.)- but generally known as bromocriptine, which bears US NIH Compound Identifier 2443. Bromocriptine most often comes in base and mesilate (mesylate) forms. European Medicines Agency schedules Bromocriptine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05918MIG. The term BROMOCRIPTINE is an International Non-Proprietary Name. World Health Organization schedules bromocriptine in its Anatomical Therapeutic Chemical (ATC) Classification. BROMOCRIPTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bromocriptine under HS 29396900 and SITC 54146. As of Q4 2014, BROMOCRIPTINE remains the US FDA Preferred Term for this commodity. Bromocriptine bears US NLM identifiers UMLS ID C0006230 and NCI Concept Code C62010. SMILES: BRC1[NH]C2C3C(C4=CC(C(=O)NC5(OC6(O)N(C(C(=O)N7C6CCC7)CC(C)C)C5=O)C(C)C)CN(C4CC13)C)CCC2.

